FDA Grants $23 Million for Rare Disease Research

Andrew Black

A large amount of money is being granted towards rare disease research development. The FDA is handing out $23 million in a siloed fund to research groups for early and later-stage rare disease research.
The funding will be distributed throughout 4 years to 21 different companies and institutions. 43% of this year’s awards fund studies that enroll pediatric patients as young as newborns. 
The FDA’s reasoning behind the funding is to help encourage clinical development of orphan drugs, biologics, medical devices, or medical foods for rare disease treatments.
“The grants awarded this year will support much-needed research in 21 different rare diseases, many of which have little, or no, available treatment options” The FDAS stated.

The Winners

Printer Printing...